1997
DOI: 10.1084/jem.186.5.719
|View full text |Cite
|
Sign up to set email alerts
|

The Lymphocyte Function–associated Antigen 1 I Domain Is a Transient Binding Module for Intercellular Adhesion Molecule (ICAM)-1 and ICAM-3 in Hydrodynamic Flow

Abstract: The I domain of lymphocyte function–associated antigen (LFA)-1 contains an intercellular adhesion molecule (ICAM)-1 and ICAM-3 binding site, but the relationship of this site to regulated adhesion is unknown. To study the adhesive properties of the LFA-1 I domain, we stably expressed a GPI-anchored form of this I domain (I-GPI) on the surface of baby hamster kidney cells. I-GPI cells bound soluble ICAM-1 (sICAM-1) with a low avidity and affinity. Flow cell experiments demonstrated a specific rolling interactio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
47
0
1

Year Published

1998
1998
2008
2008

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(54 citation statements)
references
References 47 publications
6
47
0
1
Order By: Relevance
“…In in vitro shear flow assays and in vivo, the antagonists enhance rolling of leukocytes and inhibit firm adhesion (57). These results on ICAM-1 substrates suggest that the postulated αL Glu-310-β2 MIDAS interaction is not required for rolling adhesion, in agreement with the ability of isolated, wild-type αL I domains to support rolling adhesion (58,59), but is required for firm adhesion. LFA-1 containing an αL Glu-310 → Ala mutation shows lowered expression of activation epitopes in the β2 I domain and leg, demonstrating cooperativity between the postulated αL Glu-310-β2 MIDAS interaction and conformational rearrangements elsewhere in the LFA-1 molecule.…”
Section: α/β I Domain Allosteric Antagonistssupporting
confidence: 68%
“…In in vitro shear flow assays and in vivo, the antagonists enhance rolling of leukocytes and inhibit firm adhesion (57). These results on ICAM-1 substrates suggest that the postulated αL Glu-310-β2 MIDAS interaction is not required for rolling adhesion, in agreement with the ability of isolated, wild-type αL I domains to support rolling adhesion (58,59), but is required for firm adhesion. LFA-1 containing an αL Glu-310 → Ala mutation shows lowered expression of activation epitopes in the β2 I domain and leg, demonstrating cooperativity between the postulated αL Glu-310-β2 MIDAS interaction and conformational rearrangements elsewhere in the LFA-1 molecule.…”
Section: α/β I Domain Allosteric Antagonistssupporting
confidence: 68%
“…Conceivably, the inability of the cells expressing either the ␣ M , ␤ 2 , or ␤ 2 (LB) chain alone to adhere to iC3b may be due to their lower functional affinity of these individual subunits for iC3b compared to complete ␣ M ␤ 2 heterodimer. This hypothesis is supported by the recent demonstration in a flow cell system that a GPI-linked I domain of ␣ L supports binding but not stable adhesion to immobilized ICAM-1 [56]. Other site(s) within ␣ L ␤ 2 are proposed to cooperate with the I domain, resulting in high-affinity stable adhesion between ␣ L ␤ 2 and ICAM-1.…”
Section: Expression Of Recombinant ␤ 2 Domainssupporting
confidence: 62%
“…Although the I domain is implicated as an important site for ligand binding in those integrins that contain it, we found that the isolated wild-type ␣L I domain did not support K562 transfectant binding to immobilized ICAM-1. Previous work using a glycosylphosphatidylinositol-anchored, isolated wildtype ␣L I domain has shown that ligand binding by the isolated I domain is much weaker than that by the intact integrin, and is only detected when the I domain is expressed at very high levels (33). It was suggested that the I domain alone might not be sufficient to mediate strong and stable interaction with ligand.…”
Section: Locking the Open And Closed Conformations Of The I Domain Withmentioning
confidence: 98%